Raymond James Begins Coverage on Ardelyx (NASDAQ:ARDX)
Raymond James initiated coverage on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a report released on Monday, MarketBeat.com reports. The firm issued a strong-buy rating and a $12.00 price target on the biopharmaceutical company’s stock. Several other brokerages have also recently commented on ARDX. HC Wainwright raised their price target on shares of Ardelyx […]
More Stories
Weather System Off North Carolina Could Become Nor’Easter or Tropical Storm: What to Know
By T.J. Muscaro The National Weather Service and its National Hurricane Center are tracking a storm system sitting off the...
Wall Street Review: Nasdaq Sinks 4.48 Percent as Inflation Fears Hit AI Stocks
By Panos Mourdoukoutas The Nasdaq Composite fell 4.48 percent for the week as hotter-than-expected inflation data sent Treasury yields higher...
Republican Attorney General Candidate New York, Saritha Komatireddy, Lays Out Her Vision
By Juliette Fairley Fresh off a fiery political debate last week, Republican challenger Saritha Komatireddy on Oct. 15 laid out...
Chaos and Violence Grip France as Far-Left Mobs Storm City Halls, Torch Streets
By Etienne Fauchaire PARIS—Stones and fireworks were already flying across Place de la République before Saturday’s demonstration against rising costs...
High Gas Prices Could Be the Key Issue That Swings the Senate
By Jeremy Lott Enough voters are fixated on the price of fuel that it could be the deciding issue in...
Treasury Sanctions Iraqi Bank and Iranian Shadow Networks
By Kimberly Hayek The Treasury Department has sanctioned the Iraq-based International Development Bank for Investment and Finance (IDB) and related...